Lisa Peraza Heron Therapeutics, Inc. (HRTX) insider trading activity

Lisa Peraza is VP, Chief Accounting Officer of HERON THERAPEUTICS, INC. . Currently has a direct ownership of 55,907 shares of HRTX, which is worth approximately $181,697. The most recent transaction as insider was on Jan 13, 2024, when has been sold 756 shares (Common Stock) at a price of $2.15 per share, resulting in proceeds of $1,625. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 55.9K

0% 3M change

120.89% 12M change

Total Value Held $181,697

Lisa Peraza Transaction History

Date	Transaction	Value	Shares Traded	Shares Held
Jan 13 2024	SELL Payment of exercise price or tax liability	$1,625 $2.15 p/Share	756 Reduced 1.33%	55,907 Common Stock
Jan 13 2024	BUY Exercise of conversion of derivative security	-	1,841 Added 3.15%	56,663 Common Stock
Oct 13 2023	SELL Payment of exercise price or tax liability	$619 $0.72 p/Share	860 Reduced 1.54%	54,822 Common Stock
Oct 13 2023	BUY Exercise of conversion of derivative security	-	2,484 Added 4.27%	55,682 Common Stock
Jul 25 2023	SELL Payment of exercise price or tax liability	$22,261 $1.51 p/Share	14,743 Reduced 21.7%	53,198 Common Stock
Jul 25 2023	BUY Exercise of conversion of derivative security	-	42,631 Added 38.55%	67,941 Common Stock
Jul 13 2023	SELL Payment of exercise price or tax liability	$1,126 $1.31 p/Share	860 Reduced 3.29%	25,310 Common Stock

Jul 13 2023	BUY Exercise of conversion of derivative security	-	2,485 Added 8.67%	26,170 Common Stock
Apr 13 2023	SELL Payment of exercise price or tax liability	$2,476 $2.88 p/Share	860 Reduced 3.5%	23,685 Common Stock
Apr 13 2023	BUY Exercise of conversion of derivative security	-	2,484 Added 9.19%	24,545 Common Stock
Jan 13 2023	SELL Payment of exercise price or tax liability	$3,211 $3.17 p/Share	1,013 Reduced 4.39%	22,061 Common Stock
Jan 13 2023	BUY Exercise of conversion of derivative security	-	2,485 Added 9.72%	23,074 Common Stock
Oct 13 2022	SELL Payment of exercise price or tax liability	$3,237 $3.76 p/Share	861 Reduced 4.01%	20,589 Common Stock
Oct 13 2022	BUY Exercise of conversion of derivative security	-	2,485 Added 10.38%	21,450 Common Stock
Jul 13 2022	SELL Payment of exercise price or tax liability	$2,589 $3.01 p/Share	860 Reduced 4.34%	18,965 Common Stock
Jul 13 2022	BUY Exercise of conversion of derivative security	-	2,485 Added 11.14%	19,825 Common Stock
Apr 13 2022	SELL Payment of exercise price or tax liability	$5,220 $6.07 p/Share	860 Reduced 4.73%	17,340 Common Stock
Apr 13 2022	BUY Exercise of conversion of derivative security	-	2,484 Added 12.01%	18,200 Common Stock
Jan 13 2022	SELL Payment of exercise price or tax liability	$8,018 $8.3 p/Share	966 Reduced 5.79%	15,716 Common Stock
Jan 13 2022	BUY Exercise of conversion of derivative security	-	2,485 Added 12.96%	16,682 Common Stock
Oct 13 2021	SELL Payment of exercise price or tax liability	$2,015 $10.55 p/Share	191 Reduced 1.33%	14,197 Common Stock
Oct 13 2021	BUY Exercise of conversion of derivative security	-	552 Added 3.69%	14,388 Common Stock
Jul 13 2021	SELL Payment of exercise price or tax liability	$2,575 $13.48 p/Share	191 Reduced 1.36%	13,836 Common Stock
Jul 13 2021	BUY Exercise of conversion of derivative security	-	552 Added 3.79%	14,027 Common Stock
Apr 30 2021	BUY Other acquisition or disposition	$21,267 $13.9 p/Share	1,530 Added 10.2%	13,475 Common Stock

Lisa Peraza

VP, Chief Accounting Officer

San Diego, CA

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells HRTX shares.

Notify only if

Value

Insider Trading

Get notified when an Heron Therapeutics, Inc. insider buys or sells HRTX shares.

Notify only if

Operation

Value

Type

News

Receive news related to HERON THERAPEUTICS, INC.

Track Activities on HRTX

Account